India’s pharma exports to US hit $8.9B

India’s pharma exports to the US have nearly doubled in the last 7 years, hitting an estimated $8.9 billion in FY25.

With cost-efficient manufacturing and FDA-approved facilities, Indian companies have carved out a dominant position in the generics market.

Moreover, as healthcare costs soar in the US, India’s role in keeping medicine affordable is also getting more critical.